Federal government provides $6 million in funding for national clinical trials network on COVID-19
Improving and expanding Canada’s COVID-19 response requires a coordinated research effort, and the Canadian Institutes of Health Research is contributing $6 million to create and support a Canadian network for COVID-19 clinical trials. The new body will help to expand existing networks and help coordinate the research they are doing into prevention, detection, management, and treatment of COVID-19.
Dr. Rob Fowler, a critical care physician at Sunnybrook Health Sciences Centre in Toronto, and the Canadian Critical Care Trials Group (CCCTG) have been charged with leading the new Canadian Network of COVID-19 Clinical Trials Networks. Dr. Fowler says the funding and new partnership among research networks will “help generate new treatments now for COVID, future infectious disease threats and causes of severe illness.”